During the past decade, China Medical University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "China Medical University" #1 sponsor was "China Medical University, China" with 3 trials, followed by "Huang-wei LV" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "Sun Yat-sen University" with 1 trials sponsored and "Yongtao Sun, MD, PhD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "China Medical University" #1 collaborator was "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Beijing YouAn Hospital" with 1 trials as a collaborator, "China Medical University, China" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "First Affiliated Hospital of Guangxi Medical University" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "China Medical University" are "Acute HIV Infection" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Drug Therapy" (1 trials), "Lead Poisoning" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "China Medical University" in a lesser frequency.

Most popular intervention types in "China Medical University" are "Drug" (5 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "2,3-dimercaptosuccinic acid" (1 trials), "CTL infusion" (1 trials), "FOLFOXIRI" (1 trials), "LiDCOrapid" (1 trials) and "Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R" (1 trials). Other intervention names were less common.

The vast majority of trials in "China Medical University" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "China Medical University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in China Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in China Medical University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".